• $92.0M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
16.2M
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
4.0M
N/A
N/A
N/A
N/A
N/A
Gross Profit
12.2M
N/A
0
N/A
0
N/A
Sales and Marketing Expense
42.5M
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.2M
+4.12%
-1.2M
-54.28%
-2.6M
N/A
Depreciation and Amortization Expense
1.6M
+20.12%
1.3M
-30.14%
1.9M
N/A
Total Operating Expenses
49.2M
+550.14%
7.6M
+10.33%
6.9M
N/A
Operating Profit
-32.4M
+328.32%
-7.6M
+10.33%
-6.9M
N/A
Interest Income
5,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-581,055
+3,943.53%
-14,370
N/A
Interest Income and Expense and Net
5,000
+100.86%
-581,055
+3,943.53%
-14,370
N/A
Total Nonoperating Income and Expense
-18.3M
+4,670.67%
-383,091
-26.12%
-518,509
N/A
Income before Taxes
-50.7M
+569.70%
-7.6M
+2.58%
-7.4M
N/A
Income Taxes
-7.4M
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-43.3M
N/A
N/A
N/A
-7.4M
N/A
Net Income from Continuing Operations Applicable to Common
-50.7M
N/A
N/A
N/A
-7.4M
N/A
Basic EPS and Net Income
-23.04
+1,511.19%
-1.43
-124.74%
5.78
N/A
Diluted EPS and Net Income
-23.04
+1,511.19%
-1.43
-124.74%
5.78
N/A
Basic Weighted Average Shares
1.9M
-66.27%
5.6M
+336.69%
1.3M
N/A
Diluted Weighted Average Shares
1.9M
-66.27%
5.6M
+336.69%
1.3M
N/A
Balance Sheet
Cash and Cash Equivalents
18.0M
+3,400.49%
513,443
+432.67%
96,391
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
18.0M
+3,400.49%
513,443
+432.67%
96,391
N/A
Total Current Assets
53.4M
+3,800.98%
1.4M
+1,320.41%
96,391
N/A
Accumulated Depreciation
932,000
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
9.6M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
9.6M
+1,178.13%
750,000
N/A
N/A
N/A
Total Assets
130.4M
+9,423.99%
1.4M
+1,320.41%
96,391
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
0
-100.00%
450,000
0.00%
450,000
N/A
Total Current Liabilities
26.0M
+536.58%
4.1M
-37.57%
6.5M
N/A
Total Long-Term Debt
31.4M
+23,742.78%
131,868
-82.42%
750,082
N/A
Total Long-Term Liabilities
30.1M
N/A
N/A
N/A
N/A
N/A
Total Liabilities
91.5M
+2,141.28%
4.1M
-37.57%
6.5M
N/A
Retained Earnings
-64.8M
+201.72%
-21.5M
+58.84%
-13.5M
N/A
Total Stockholders Equity
38.9M
N/A
N/A
N/A
-6.4M
N/A
Total Shares Outstanding
3.2M
-47.01%
6.1M
+55.93%
3.9M
N/A
Cash Flow
Cash from Operating Activities
-22.6M
+289.99%
-5.8M
+490.45%
-981,031
N/A
Capital Expenditures
99,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-5.2M
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
45.3M
+630.10%
6.2M
+507.38%
1.0M
N/A
Financials Ratio
Gross Margin
75.39%
N/A
N/A
N/A
N/A
N/A
Operating Margin
-200.11%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-65.75%
N/A
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.05
+512.82%
0.34
N/A
N/A
N/A
Cash Ratio
0.69
+450.12%
0.13
N/A
N/A
N/A
Debt-to-Equity Ratio
0.81
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.24
-43.27%
0.43
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow